A CDMO RFQ should define molecule, stage, quantity, quality target, analytical expectations, presentation, regulatory context, timing and decision milestones.
What procurement and laboratory teams should review
Separate must-have requirements from preferred options
State current development history and available methods
Define batch scale, number of campaigns and future scale expectations
List documentation, quality-agreement and destination needs
Translate a scientific request into a controlled project
A useful custom peptide brief connects sequence and modifications with scale, purity, analytical package, final presentation and intended research workflow. Early feasibility review reduces avoidable changes after synthesis has started.
- Separate essential acceptance criteria from preferences.
- Identify difficult motifs, modifications or scale constraints early.
- Agree deliverables, change control and repeat-supply expectations.
Questions to resolve before quotation or release
- What project stage and decision will the material support?
- Which deliverables must be priced separately?
- What information is confidential and requires an NDA?
The HK PEPTIDES inquiry center provides a starting structure; complex RFQs can follow by email with sequence files and technical attachments.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.